Smallpox

The search for a safer smallpox vaccine: new data on promising candidate

Published in Medical Letter on the CDC and FDA, June 20th, 2004

When used as an aerosolized weapon, smallpox could be controlled by a new vaccine under study at St. Louis University School of Medicine, according to new data.

Detailed results from studies by Dr. Mark Buller of St. Louis University School of Medicine were presented at the Seventh Annual Conference on Vaccine Research, sponsored by the National Foundation for Infectious Diseases, in Arlington, Virginia. The research tested the efficacy of a smallpox vaccine candidate known as LC16m8.

The research conducted at St. Louis University by Buller and his colleagues has demonstrated that the vaccine, given to mice, protects against a virus related to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-06-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry